Project description:To study the epigenome profile of melanoma cells upon mcFAs administration, we stimulated A375 cells using octanoate for 48-hrs followed by ATAC-seq analysis with 2 biological replicates.
Project description:To study the epigenome profile of melanoma cells upon mcFAs administration, we stimulated A375 cells using octanoate for 48-hrs followed by H3K27ac ChIP-seq analysis with 2 biological replicates.
Project description:Identify transcriptionnally and translationally regulated mRNA in melanoma parental and persister cells In this dataset, we include expression data of A375 melanoma drug-naïve parental cells and A375 melanoma persister cells that survived from BRAF and MEK inhibition. The expression data are studied in both total RNA and polysome-bounded RNA.
Project description:To study chromatin accessibility of melanoma cells upon reHMGA1 uptake, we stimulated A375 cells using recombinant HMGA1 for 2 and 18-hrs followed by ATAC-seq analysis with 2 biological replicates.
Project description:BRAF-inhibitor (BRAFi)-resistance compromises long term survivorship of malignant melanoma patients, and mutant NRAS is a major mediator of BRAFi-resistance. We have employed NanoString nCounterTM transcriptomic analysis of isogenic human malignant melanoma cells that differ only by NRAS mutational status (BRAFi-sensitive A375-BRAFV600E/NRASQ61 versus BRAFi-resistant A375-BRAFV600E/NRASQ61K), identifying modulation of specific gene expression networks as a function of NRASQ61K-status.
Project description:Analysis of effect of CD10 in melanoma at gene expression level. The hypothesis tested in the present study was that CD10 promotes melanoma tumor progression. Results provide important information of the significant gene expression change between CD10-transfected and mock-transfected A375 cells, such as significantly increased genes included those related to anti-apoptosis, angiogenesis and cell proliferation. Total RNA obtained from CD10-transfected A375 melanoma cells was that from compared to mock-transfected A375 cells.